Today's Analyst Rating | Chevron Price Target Raised to $205 by BMO Capital, BofA Securities Cuts Its Price Target Cut on UnitedHealth to $337
Wall Street analysts updated their ratings today including $Chevron (CVX.US)$ and $UnitedHealth (UNH.US)$, according to TipRanks.
Upgrades:
BMO Capital analyst Phillip Jungwirth maintains $Chevron (CVX.US)$ with buy rating, and adjusts the target price from USD190 to USD205.
UBS analyst Erika Najarian upgrades $Morgan Stanley (MS.US)$ to buy rating, and adjusts the target price from USD165 to USD196.
Wells Fargo analyst Aaron Rakers maintains $Intel (INTC.US)$ with hold rating, and adjusts the target price from USD45 to USD55.
Downgrades:
BofA Securities analyst Kevin Fischbeck maintains $UnitedHealth (UNH.US)$ with hold rating, and adjusts the target price from USD410 to USD337.
UBS analyst Erika Najarian maintains $Goldman Sachs (GS.US)$ with hold rating, and adjusts the target price from USD990 to USD930.
Barclays analyst Benjamin Budish maintains $Charles Schwab (SCHW.US)$ with buy rating, and adjusts the target price from USD126 to USD117.
For more trending U.S. stock ratings today, refer to the chart below:
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CandyBomb x PWT (Episode 2): Trade to share 45,000 USDT
Announcement on the removal of the "Signal Calls" feature from the app
[Initial listing] Bitget to list MAGNE.AI (MHA)
CandyBomb x DGAI (Episode 2): Trade to share 50,000 USDT

